cycloheximide has been researched along with gambogic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Chen, D; Dong, X; Dou, QP; Guo, H; Huang, H; Li, S; Li, X; Liu, J; Liu, N; Liu, S; Lu, X; Yang, C; Zhang, C; Zhao, C; Zhao, K; Zhou, P | 1 |
| Gu, HY; Guo, QL; Mu, R; Qi, Q; Rong, JJ; Tao, L; Wang, J; You, QD; Zhao, Q; Zou, MJ | 1 |
3 other study(ies) available for cycloheximide and gambogic acid
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Gambogic acid enhances proteasome inhibitor-induced anticancer activity.
Topics: Amino Acid Chloromethyl Ketones; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Boronic Acids; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cell Survival; Cycloheximide; Cysteine Proteinase Inhibitors; Drug Synergism; Humans; K562 Cells; Leupeptins; Male; Mice; Neoplasms, Experimental; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Synthesis Inhibitors; Signal Transduction; Transplantation, Homologous; Tumor Burden; Xanthones | 2011 |
Gambogic acid-induced degradation of mutant p53 is mediated by proteasome and related to CHIP.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Survival; Cycloheximide; Humans; Immunohistochemistry; Immunoprecipitation; Mice; Mice, Nude; Neoplasms; Proteasome Endopeptidase Complex; Protein Binding; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Tumor Suppressor Protein p53; Ubiquitin-Protein Ligases; Xanthones; Xenograft Model Antitumor Assays | 2011 |